Luzitin presents innovative solutions in the US

2015-06-19 in Press Release Luzitin

From the 15th to 18th June, Luzitin was in the United States, at BIO International Convention, with the Portuguese delegation. The company is offering innovative therapeutic solutions for cancer therapy.

Luzitin integrates the Portugal’s Biotechnology Industry Association (P-BIO) and was represented at the Portuguese booth (1701) at the exhibition of BIO International Convention. The event is the world’s largest biotechnology gathering and took place in Philadelphia, Pennsylvania (US).

The company offers innovative therapeutic solutions for cancer therapy. Its proprietary technology consists of a combination of a new generation photosensitizer (redaporfin) with a specific infrared-laser medical device.

At BIO International Convention, Luzitin was seeking for partners in order to further its technology development. The company’s main compound (redaporfin) aims the worldwide market, so Luzitin looks for companies with the potential to in-license its pipeline products and investors willing to proceed with the development of redaporfin.

BIO International Convention has featured more than 1,700 exhibitors pursuing partnering opportunities and aiming to discover new players in the industry, as well as emerging technologies.



Bluepharma
Bluepharma
Bluepharma
Bluepharma
Bluepharma
Bluepharma